← Back to Search

Self-Management Group for Post-COVID Syndrome

N/A

Waitlist Available

Led By Tracy Herring, PhD

Research Sponsored by University of Washington

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up collected via online survey at pre-treatment (up to 1 month before tx session 1) and post-treatment (up to 2 months after tx session 6)

Awards & highlights

Study Summary

This trial uses telemedicine to help adults with Post-COVID symptoms manage them better and cope better.

Who is the study for?

This trial is for adults over 18 in Washington state with Post-COVID conditions who can read and speak English. They need a phone and internet to participate. It's not for those getting other psychosocial treatments for Post-COVID symptoms or those with severe cognitive issues.Check my eligibility

What is being tested?

The COPE Study tests a telemedicine group intervention lasting 6 weeks, aimed at helping adults manage their symptoms and cope better after COVID-19. Participants are randomly chosen to either join the program or not, to compare outcomes.See study design

What are the potential side effects?

Since this study focuses on self-management and coping strategies rather than medication, it does not have typical drug side effects. However, participants may experience emotional discomfort discussing their condition.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ collected via online survey at pre-treatment (up to 1 month before tx session 1) and post-treatment (up to 2 months after tx session 6)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~collected via online survey at pre-treatment (up to 1 month before tx session 1) and post-treatment (up to 2 months after tx session 6)

This trial's timeline: 3 weeks for screening, Varies for treatment, and collected via online survey at pre-treatment (up to 1 month before tx session 1) and post-treatment (up to 2 months after tx session 6) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Intervention Acceptability

Intervention Appropriateness

Intervention Feasibility

Secondary outcome measures

Anxiety Symptoms

Depressive Symptoms

Fatigue

+7 more

Trial Design

2Treatment groups

Active Control

Group I: 6-Week Waitlist GroupActive Control1 Intervention

6-week waitlist period during which participants will complete study assessments. After completing the study, waitlist participants will be offered the active intervention.

Group II: 6-Week Self-Management GroupActive Control1 Intervention

6-week telemedicine group-based intervention designed to improve symptom management and coping in adults with Post-COVID. The intervention consists of six weekly group sessions that are 1.5 hours long. Group size is 8-10 participants.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of WashingtonLead Sponsor

1,739 Previous Clinical Trials

1,847,877 Total Patients Enrolled

Tracy Herring, PhDPrincipal InvestigatorUniversity of Washington

Lindsey Knowles, PhDPrincipal InvestigatorUniversity of Washington

1 Previous Clinical Trials

21 Total Patients Enrolled

Media Library

6-Week Self-Management Group Clinical Trial Eligibility Overview. Trial Name: NCT05658536 — N/A

Post-COVID Syndrome Research Study Groups: 6-Week Waitlist Group, 6-Week Self-Management Group

Post-COVID Syndrome Clinical Trial 2023: 6-Week Self-Management Group Highlights & Side Effects. Trial Name: NCT05658536 — N/A

6-Week Self-Management Group 2023 Treatment Timeline for Medical Study. Trial Name: NCT05658536 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is enrolment still open for this research endeavor?

"Yes, the information posted on clinicaltrials.gov confirms that this medical study is actively seeking out participants - with a goal of recruiting 50 patients from one site. This trial was first listed on January 1st 2023 and its details were last updated on December 1st 2023."

Answered by AI

How many participants have enrolled in this experiment thus far?

"Affirmative. According to clinicaltrials.gov, the recruitment for this medical trial has been ongoing since it was first posted on January 1st 2023 and is still open as of December 1st 2023. This study seeks fifty participants from a single site."

Answered by AI

What can be gleaned from this research endeavor?

"This clinical trial is aiming to gauge the Intervention Acceptability of participants over a 2-month post-treatment period, with secondary outcomes such as Pain Interference and Fatigue being assessed via PROMIS T scores. Additionally, Impression of Change will be evaluated through a one-item scale that reflects subjective perceptions."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

The COPE Study: Pilot Intervention to Improve Symptom Self-management and Coping in Adults With Post COVID-19

Tracy Herring 2023. "The COPE Study: Pilot Intervention to Improve Symptom Self-management and Coping in Adults With Post COVID-19". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05658536.